Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study

With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui, Zhao, Changming, Jiang, Shuxia, Zhang, Zhaohua, Ban, Chunmei, Zheng, Guiping, Hou, Yan, Jin, Bingjin, Shi, Yannan, Wu, Xin, Zhao, Qiangqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588980/
https://www.ncbi.nlm.nih.gov/pubmed/36299285
http://dx.doi.org/10.3389/fbioe.2022.1027868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588980/
https://www.ncbi.nlm.nih.gov/pubmed/36299285
http://dx.doi.org/10.3389/fbioe.2022.1027868

Ejemplares similares